Rapid Micro Biosystems (NASDAQ:RPID) Releases Earnings Results, Meets Expectations

Rapid Micro Biosystems (NASDAQ:RPID) released its quarterly earnings results on Friday. The company reported ($0.26) EPS for the quarter, hitting the consensus estimate of ($0.26), Zacks reports. Rapid Micro Biosystems had a negative return on equity of 63.07% and a negative net margin of 145.63%.The business had revenue of $7.84 million for the quarter, compared to analysts’ expectations of $7.60 million. Rapid Micro Biosystems updated its FY 2025 guidance to EPS.

Rapid Micro Biosystems Price Performance

Shares of NASDAQ:RPID traded up $0.35 during trading on Friday, reaching $3.10. 127,335 shares of the company’s stock traded hands, compared to its average volume of 82,886. The stock has a market capitalization of $137.05 million, a P/E ratio of -3.07 and a beta of 1.37. Rapid Micro Biosystems has a 12 month low of $0.87 and a 12 month high of $4.50. The company has a 50 day moving average of $3.06 and a 200-day moving average of $3.13.

Analyst Ratings Changes

RPID has been the topic of several analyst reports. Weiss Ratings restated a “sell (d-)” rating on shares of Rapid Micro Biosystems in a report on Wednesday, October 8th. Lake Street Capital started coverage on shares of Rapid Micro Biosystems in a research note on Monday, July 28th. They issued a “buy” rating and a $8.00 price target for the company. Finally, Wall Street Zen downgraded shares of Rapid Micro Biosystems from a “hold” rating to a “sell” rating in a research note on Saturday. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $8.00.

Hedge Funds Weigh In On Rapid Micro Biosystems

Institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. lifted its holdings in shares of Rapid Micro Biosystems by 6.7% in the 3rd quarter. Vanguard Group Inc. now owns 965,018 shares of the company’s stock worth $3,223,000 after purchasing an additional 60,655 shares during the last quarter. XTX Topco Ltd acquired a new stake in Rapid Micro Biosystems in the second quarter worth $144,000. American Century Companies Inc. lifted its stake in Rapid Micro Biosystems by 46.1% in the second quarter. American Century Companies Inc. now owns 16,922 shares of the company’s stock valued at $58,000 after buying an additional 5,341 shares during the last quarter. Finally, Geode Capital Management LLC boosted its holdings in shares of Rapid Micro Biosystems by 1.6% during the second quarter. Geode Capital Management LLC now owns 204,079 shares of the company’s stock valued at $704,000 after acquiring an additional 3,143 shares during the period. 52.60% of the stock is owned by institutional investors.

About Rapid Micro Biosystems

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.